HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J W Scheeren Selected Research

N- (4- doxorubicin- N- carbonyl(oxymethyl)phenyl)- O- glucuronyl carbamate

2/2001Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
2/2001A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J W Scheeren Research Topics

Disease

2Ovarian Neoplasms (Ovarian Cancer)
02/2001 - 02/2001
1Neoplasms (Cancer)
02/2001
1Necrosis
02/2001

Drug/Important Bio-Agent (IBA)

2N- (4- doxorubicin- N- carbonyl(oxymethyl)phenyl)- O- glucuronyl carbamateIBA
02/2001 - 02/2001
2ProdrugsIBA
02/2001 - 02/2001
1Pharmaceutical PreparationsIBA
02/2001
1EnzymesIBA
02/2001
1GlucuronidaseIBA
02/2001
1Immunoconjugates (Immunoconjugate)IBA
02/2001
1Epithelial Cell Adhesion MoleculeIBA
02/2001
1Monoclonal AntibodiesIBA
02/2001
1GlucuronidesIBA
02/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2001

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2001